We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.77%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$52.5B
AUM Growth
+$13.1B
(+33%)
Cap. Flow
+$7.72B
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
2,462
New
319
Increased
921
Reduced
776
Closed
312
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$436M |
| 3 |
Apple
AAPL
|
+$415M |
| 4 |
Microsoft
MSFT
|
+$396M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$120M |
| 2 |
Walt Disney
DIS
|
+$115M |
| 3 |
Wingstop
WING
|
+$89.6M |
| 4 |
Cisco
CSCO
|
+$88.1M |
| 5 |
Amphenol
APH
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Healthcare | 10.33% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CONMED
CNMD
$1.29B
| $240K | ﹤0.01% |
4,603
+780
| +20% | +$42.8K |
|
1902
Assembly Biosciences
ASMB
$506M
| $240K | ﹤0.01% |
13,227
-4,725
| -26% | -$62.3K |
|
1903
Weis Markets
WMK
$1.82B
| $239K | ﹤0.01% |
3,296
-2,580
| -44% | -$202K |
|
1904
Civista Bancshares
CIVB
$594M
| $239K | ﹤0.01% |
10,291
-584
| -5% | -$12.7K |
|
1905
CSX Corp
CSX
$98.6B
| $238K | ﹤0.01% |
7,305
-892,109
| -99% | -$26.8M |
|
1906
TAL Education Group
TAL
$5.71B
| $238K | ﹤0.01% |
23,270
-1,269,471
| -98% | -$13.1M |
|
1907
Clear Secure
YOU
$5.26B
| $237K | ﹤0.01% |
8,544
-23,483
| -73% | -$598K |
|
|
ECHO
1908
EchoStar
ECHO
$25.5B
| $237K | ﹤0.01% |
+8,555
| New | +$188K |
|
1909
United States Antimony
UAMY
$766M
| $237K | ﹤0.01% |
+108,558
| New | +$308K |
|
|
NPKI
1910
NPK International
NPKI
$1.21B
| $236K | ﹤0.01% |
+27,748
| New | +$203K |
|
1911
Crescent Energy
CRGY
$3.72B
| $236K | ﹤0.01% |
27,457
-91,647
| -77% | -$802K |
|
1912
SIGA Technologies
SIGA
$223M
| $236K | ﹤0.01% |
36,199
+234
| +0.7% | +$1.4K |
|
1913
Limbach Holdings
LMB
$867M
| $235K | ﹤0.01% |
1,677
-3,623
| -68% | -$411K |
|
|
VRE
1914
DELISTED
Veris Residential
VRE
| $234K | ﹤0.01% |
15,722
-53,515
| -77% | -$823K |
|
1915
BioLife Solutions
BLFS
$1.46B
| $234K | ﹤0.01% |
+10,862
| New | +$245K |
|
1916
MediaAlpha
MAX
$710M
| $232K | ﹤0.01% |
+21,145
| New | +$204K |
|
1917
Aurinia Pharmaceuticals
AUPH
$1.97B
| $231K | ﹤0.01% |
+27,292
| New | +$219K |
|
1918
Natural Gas Services Group
NGS
$470M
| $231K | ﹤0.01% |
+8,947
| New | +$201K |
|
1919
Byline Bancorp
BY
$1.75B
| $231K | ﹤0.01% |
8,636
-732
| -8% | -$18.8K |
|
1920
Liquidity Services
LQDT
$1.17B
| $231K | ﹤0.01% |
9,775
-1,430
| -13% | -$38.6K |
|
|
ACH
1921
Accendra Health
ACH
$240M
| $230K | ﹤0.01% |
+25,247
| New | +$186K |
|
1922
Repligen
RGEN
$7.44B
| $226K | ﹤0.01% |
1,817
-45,584
| -96% | -$5.8M |
|
1923
Hanmi Financial
HAFC
$943M
| $226K | ﹤0.01% |
9,149
-8,896
| -49% | -$203K |
|
|
PKST
1924
DELISTED
Peakstone Realty Trust
PKST
| $225K | ﹤0.01% |
+17,045
| New | +$209K |
|
1925
CG Oncology
CGON
$6.11B
| $224K | ﹤0.01% |
+8,619
| New | +$208K |
|
Similar funds
Man Group's Q2 2025 Portfolio in Review
As of Q2 2025, Man Group held 2,462 positions worth $52.5B, up 33% from $39.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group deployed $7.72B of net new capital in Q2 2025, opening 319 new positions and adding to 921 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Booz Allen Hamilton, an estimated $120M trimmed.
- Man Group's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
- Man Group added most to NVIDIA in Q2 2025, an estimated $436M increase.
- Man Group's biggest Q2 2025 reduction was Booz Allen Hamilton, cutting an estimated $120M.
- Man Group fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $81.9M.
- Man Group's ten largest holdings make up 17% of its $52.5B portfolio in Q2 2025.
- Man Group opened 319 new positions and closed 312 in Q2 2025.
- Man Group's portfolio value rose 33% quarter-over-quarter to $52.5B.
Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.